Adial Pharmaceuticals, Inc. (ADIL) NASDAQ
1.56
-0.01(-0.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.56
-0.01(-0.64%)
Currency In USD
| Market Cap | 3.68M |
| Enterprise Value | -2.2M |
| P/E Ratio | -0.22 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.33 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.17 |
| Return On Equity | -1.82 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -565 |
| EBITDA | -7.8M |
| Net Income | -7.98M |
| Diluted EPS | -11.93 |
| Total Cash | 5.88M |
| Total Cash/Share | 5.29 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.42 |
| Book Value Per Share | 4.75 |
| 52-Week Change | -91.09 |
| 52-Week High | 30.25 |
| 52-Week Low | 1.53 |
| Moving Average 50 Days | 2 |
| Moving Average 200 Days | 6.74 |
| Average Volume | 106,164 |
| Shares Outstanding | 959,644 |
| % Held by Institutions | 15.95 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | February 06, 2026 |